Journals / MN Kardiyoloji / 2001 / Cilt: 8 - Sayı: 1

Succesfull treatment of cardiogenic shock due to acute massive pulmonary embolism with tissue plasminogen activator (tPA): Case report

Doku plazminojen aktivatörü (tPA) ile akut masif pulmoner emboliye bağlı kardiyojenik şokun başarılı tedavisi ( Olgu sunumu )

Pages
55–57
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We thought that presentation of this case of acute massive pulmonary embolism with cardiogenic shock who was successfully treated with tPA and inferior vena caval filter would be interesting.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Most pulmonary emboli result from thrombi in the pelvic or deep veins of the leg.
📊
Key Findings & Data:Acute massive pulmonary embolism patients are at risk of developing cardiogenic shock.
💡
Conclusion & Impact:We thought that presentation of this case of acute massive pulmonary embolism with cardiogenic shock who was successfully treated with tPA and inferior vena caval filter would be interesting.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Vena kava · inferior · Trombolitik tedavi

Abstract

Most pulmonary emboli result from thrombi in the pelvic or deep veins of the leg. Acute massive pulmonary embolism patients are at risk of developing cardiogenic shock. In addition to anticoagulant therapy, primary treatment of pulmonary embolism with thrombolysis or mechanical intervention and inferior vena caval filter replacement for secondary prevention are advocated. We thought that presentation of this case of acute massive pulmonary embolism with cardiogenic shock who was successfully treated with tPA and inferior vena caval filter would be interesting.

Özet

Pulmoner emboli vakalarında trombusun kaynağı çoğunlukla pelvik ve derin bacak venleridir. Akut masif pulmoner emboli geçiren hastalar kardiyojenik şok gelişimi açısından risk altındadırlar.Pulmoner embolide antikoagülan tedavinin yanısıra , birincil tedavi olarak tromboliz veya mekanik müdahaleler ve ikincil korumada inferior vena kavaya filtre yerleştirilmesi önerilmektedir.tPA ve inferior vena kava filtresi ile başarılı olarak tedavi edilen , kardiyojenik şok tablosu ile seyreden akut masif pulmoner emboli vakamızın sunulmasının yararlı olacağı düşünülmüştür.

🔖

Cite This Article

VURUŞKAN, E., GÜLBAY, M., KURTUL, A., TUTAR, E., ORAL, D. (2001). Succesfull treatment of cardiogenic shock due to acute massive pulmonary embolism with tissue plasminogen activator (tPA): Case report. MN Kardiyoloji, Cilt: 8 - Sayı: 1, 55–57. https://ajindex.com/articles/297852

References (2)

  1. Sandier DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: Are we detecting enough deep vein thrombosis ?J. R. Soc. Med.: 82-203, 1989. Braunwald E. Heart Disease. Pulmonary Embolism: WB Saunders Company 1997:1596. Urokinase Pulmonary Embolism Trial: A National Cooperative Study. Circulation 47 and 48 (Suppl. ll):1,1973.
  2. Goldhaber SZ, Haire WD.: Alteplase versus heparin in acute pulmonary embolism: Randomized trial assessing right-ventricular function and pulmonary perfusion. Lancet 1993;341:507. Goldhaber SZ. Contemporary pulmonary embolism thrombolysis. Chest 1995;107:45S. Braunwald E.: Atlas of Heart Diseases, Vol III.Current Medicine, 1995:3.1-3.25.